[Benign circumscribed erythroplasia-like vulvo-vaginitis; associated vaginal moniliasis; favorable effect of mycostatin].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002177:Candidiasis / Q000628:therapy*; D004919:Erythroplasia; D005260:Female; D006801:Humans; D059413:Intraabdominal Infections; D009761:Nystatin; D014627:Vaginitis / Q000150:complications*; D014844:Vulva
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D009761:Nystatin
ANTIBIOTICS/therapeutic use; MONILIASIS/therapy; VAGINITIS/complications
Vulvo-vaginite bénigne circonscrite, érythroplasiforme; moniliase vaginale associée; rôle favorable de la mycostatine.